We are live on ! Find out more
BRTX icon

BioRestorative Therapies
BRTX

21 hedge funds and large institutions have $1M invested in BioRestorative Therapies in 2026 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

444% more capital invested

Capital invested by funds: $184K → $1M (+$818K)

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

91% more funds holding

Funds holding: 11 → 21 (+10)

7.8% more ownership

Funds ownership: 2.66% → 10.46% (+7.8%)

Holders
21
Holders Change
+10
Holders Change %
+90.91%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
4
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$235K
2
HF
HRT Financial
New York
+$208K
3
XT
XTX Topco
Cayman Islands
+$83.8K
4
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust
Pennsylvania
+$41.5K
5
Citigroup
Citigroup
New York
+$18.6K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$29.2K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$20.7K

BRTX Hedge Fund Activity: Q2 2026 in Review

21 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in BioRestorative Therapies (BRTX) for Q2 2026, worth a combined $1M — up 444% from $184K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new BRTX positions and 0 closed out — a net gain of 10 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $235K. The largest seller was UBS Group, cutting an estimated $29.2K.

  • 21 institutional investors held BioRestorative Therapies (BRTX) as of Q2 2026, up from 11 in Q1 2026.
  • Funds reported $1M of BioRestorative Therapies stock for Q2 2026, up 444% quarter-over-quarter.
  • 10 funds opened new BioRestorative Therapies positions in Q2 2026 and 0 closed out, a net change of +10 holders.
  • The largest BioRestorative Therapies buyer in Q2 2026 was Jane Street, an estimated $235K added.
  • The largest BioRestorative Therapies seller in Q2 2026 was UBS Group, an estimated $29.2K sold.

Based on aggregated 13F filings for Q2 2026.